MIMS news

New obesity treatment targets appetite and reward pathways in the brain

New obesity treatment targets appetite and reward pathways in the brain

Mysimba (naltrexone/bupropion) can be used alongside...

Cardiovascular warning for rosacea gel

Cardiovascular warning for rosacea gel

Patients using the topical rosacea treatment brimonidine...

Eluxadoline: first treatment option for IBS patients with diarrhoea

Eluxadoline: first treatment option for IBS patients with diarrhoea

Truberzi (eluxadoline) is a new orally administered...

New antibody prevents recurrence of Clostridium difficile infection

New antibody prevents recurrence of Clostridium difficile infection

Zinplava (bezlotoxumab) is a human monoclonal antibody...

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI (salmeterol/fluticasone) is indicated...

Claim your free place at MIMS Learning Live in Manchester on 14th June

Claim your free place at MIMS Learning Live in Manchester on 14th June

There's still time to register for MIMS Learning Live...

NICE approves further treatment options for psoriatic arthritis

NICE approves further treatment options for psoriatic arthritis

Certolizumab pegol (Cimzia) and secukinumab (Cosentyx)...

Quinine for muscle cramps linked to increased mortality

Quinine for muscle cramps linked to increased mortality

Long-term use of quinine for nocturnal leg cramps may...

First drug approved for diabetes prevention

First drug approved for diabetes prevention

Glucophage SR (sustained-release metformin) has gained...

Inhaler options multiply with launch of new salmeterol/fluticasone MDI

Inhaler options multiply with launch of new salmeterol/fluticasone MDI

Sereflo (salmeterol/fluticasone) is indicated for adults...

New MS treatment accepted by NICE

New MS treatment accepted by NICE

Eligible patients with multiple sclerosis (MS) must...

NHS approval for latest psoriasis biologic

NHS approval for latest psoriasis biologic

NICE has recommended ixekizumab (Taltz) as an option...

Methotrexate available in button-free auto-injector

Methotrexate available in button-free auto-injector

Rheumatoid arthritis patients who struggle to use existing...

Pictorial inhaler guide published on MIMS website

Pictorial inhaler guide published on MIMS website

Images and key features of inhalers and other respiratory...

Baricitinib: oral rheumatoid arthritis treatment in new drug class

Baricitinib: oral rheumatoid arthritis treatment in new drug class

Olumiant (baricitinib) 4mg tablets are now available...

Tofacitinib: new type of rheumatoid arthritis treatment launches

Tofacitinib: new type of rheumatoid arthritis treatment launches

Xeljanz (tofacitinib) is a new oral treatment option...

Report reactions to legal highs via new website, GPs urged

Report reactions to legal highs via new website, GPs urged

GPs are being encouraged to report adverse reactions...

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Aerivio Spiromax provides the same metered dose of...

New combination antibiotic for serious infections

New combination antibiotic for serious infections

Zavicefta (ceftazidime/avibactam) is a new combination...

Rapid-acting insulin aspart launched

Rapid-acting insulin aspart launched

Fiasp is a formulation of insulin aspart that includes...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases